Germany's Curetis Begins Clinical Trial for MDx Platform, Pneumonia Test Cartridge
March 01, 2012
Germany's Curetis Begins Clinical Trial for MDx Platform, Pneumonia Test Cartridge
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- German MDx Startup Curetis Nets Roche Venture Fund, Forbion as New Investors
October 27, 2011 / PCR Insider - Germany's Curetis Adds $6.4M to Series A Financing to Prep MDx System for US Trials
May 19, 2011 / PCR Insider - Dx Focus: IdahoTech FilmArray; Curetis Unyvero Pneumonia Assay; IMDx GBS Test; Lab21's US CLIA Lab
May 17, 2012 / PCR Insider - Dx Focus: PEPFAR Funding Drives Cepheid TB Test Uptake; Curetis Starts US Trials for MDx System
December 6, 2012 / PCR Insider - Curetis, Heraeus Medical Partner to Develop MDx Test for Implant, Tissue Infections
September 20, 2012 / PCR Insider